menu
    • menu
    [{"orgOrder":0,"company":"Kirin Holdings","sponsor":"Biofortis Clinical Research, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings \/ Biofortis Clinical Research, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings \/ Biofortis Clinical Research, Inc."},{"orgOrder":0,"company":"Kirin Holdings","sponsor":"The Center for Applied Health Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings \/ The Center for Applied Health Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings \/ The Center for Applied Health Sciences"},{"orgOrder":0,"company":"Kirin Holdings","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Cognizin","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings \/ Nutrasource"}]

    Find Clinical Drug Pipeline Developments & Deals by Kirin Holdings

    Menu

    Kirin Holdings

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : The Center for Applied Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluate the Effects of Citicoline on Mood in Healthy Adults

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 28, 2025

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : The Center for Applied Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cognizin

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Nutrasource

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluate the Effects of Citicoline on Cognitive Performance in Healthy Adults

                            Details : Cognizin is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 02, 2025

                            Lead Product(s) : Cognizin

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Nutrasource

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 19, 2021

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth